xencor.com (XNCR) - Volume dana dhuwit perusahaan

Simbol resmi perusahaan Xencor, Inc. (XNCR)

Xencor, Inc. (XNCR) engineers antibodies for tumor therapy, generating long-term royalties through the versatility of its developments. Intellectual property protection and the XmAb platform enable the company to avoid price wars. Early-stage trial risks are mitigated by substantial upfront payments from partners. The cash balance reflects resource dynamics, with the latest value recorded as 0.40.

XNCR - Cadangan dhuwit perusahaan Xencor Corp ing rentang 04.07.2022 - 21.11.2026

Rincian analitis perusahaan Xencor, Inc.

- rega saiki lan proyeksi nilai saham:
Pambiji fundamental perusahaan:Xencor Inc XNCR
Produk merek Xencor

Xencor, Inc. generates revenue through licensing fees and upfront payments from pharmaceutical behemoths for access to the XmAb platform. By analyzing the cash and cash equivalents metric, an investor assesses the volume of highly liquid assets, which determines the company's ability to fund development without external borrowing during periods of tight monetary policy, characterizing these securities as a high-tech asset with a specific liquidity profile.

Pesaing Xencor, Inc. (XNCR)

Dhuwit awis perusahaan IBRX (ImmunityBio Corp)|Gunggung dana dhuwit perusahaan IMCR|Volume dana dhuwit perusahaan JANX (Janux Therapeutics, Inc.)|Sisa dhuwit perusahaan RCUS|zymeworks.com - Volume dana dhuwit perusahaan|Cadangan dhuwit perusahaan Tango Therapeutics Corp|Iovance Biotherapeutics (IOVA) - Dana dhuwit perusahaan|Immatics N.V. - Sisa dhuwit perusahaan|CMPX (compasstherapeutics.com) - Volume dana dhuwit perusahaan|Volume dana dhuwit perusahaan Replimune Group Inc|Dana dhuwit perusahaan Lyell Immunopharma, Inc. (LYEL)|IPHA: Total volume dana dhuwit perusahaan|Pyxis Oncology - Dhuwit awis perusahaan|Compugen Limited (CGEN) - Cadangan dhuwit perusahaan|IO Biotech Inc - Volume dana dhuwit perusahaan|Aset likuid perusahaan Sutro Bio STRO|INKT: Volume dana dhuwit perusahaan|Cadangan dhuwit perusahaan Werewolf (HOWL)|Dana dhuwit perusahaan immixbio.com|Dhuwit awis lan setara dhuwit awis perusahaan ALXO (ALX Oncology)|Volume dana dhuwit perusahaan CUE|PDSB (PDS Biotechnology Corporation) - Sisa dhuwit perusahaan|Volume dana dhuwit perusahaan SONN (Sonnet BioTherapeutics Holdings)|Sisa dhuwit perusahaan MAIA|Liminatus - Volume dana dhuwit perusahaan|lavatherapeutics.com - Gunggung dana dhuwit perusahaan|NextCure (NXTC) - Dana dhuwit perusahaan|Leap Therapeutics Inc - Sisa dhuwit perusahaan|Dhuwit awis perusahaan INTS|Dana dhuwit perusahaan SNSE|Volume dana dhuwit perusahaan TOVX|GRTS - Cadangan dhuwit perusahaan|Dana dhuwit perusahaan kinetabio.com KA|Sisa dhuwit perusahaan NEXI|turnstonebio.com - Volume dana dhuwit perusahaan|VCNX (Vaccinex, Inc) - Dhuwit awis lan setara dhuwit awis perusahaan|Harpoon Therapeutics (HARP) - Dana dhuwit perusahaan